Chembio Diagnostics (CEMI) Financials

$0.46

$0.00 (0.22%)

As on 27-Apr-2023 16:00EDT

Market cap

$17 Mln

Revenue (TTM)

$48 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	48.34	36.93	30.45	34.46	33.41	24.02
Cost of Revenue	38.58	34.50	23.87	22.39	21.43	12.92
Gross Profit	9.76	2.43	6.58	12.07	11.98	11.09
Operating Expenses	30.16	26.44	28.53	24.68	19.63	17.58
Operating Profit (EBIT)	-20.40	-24.01	-21.95	-12.61	-7.65	-6.48
Other Income	--	--	--	--	0.05	0.02
Profit before Tax	-23.26	-33.97	-25.98	-14.18	-7.93	-6.46
Provision for Tax	0.03	-0.06	-0.46	-0.50	-0.07	-0.09
Profit after Tax (Net Income)	-23.29	-33.90	-25.52	-13.68	-7.87	-6.37
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	-33.90	-25.52	-13.68	-7.87	-6.37

Liabilities ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	17.80	34.26	27.78	24.04	33.33	13.08
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	5.51	23.70	24.76	25.25	1.06	0.44
Current Liabilities	39.30	15.28	12.35	6.44	6.52	3.10
Total Liabilities	62.61	73.25	64.89	55.73	40.91	16.62

Assets ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	14.16	18.41	25.15	23.51	12.46	5.76
Current Assets	48.45	54.84	39.74	32.22	28.45	10.85
Total Assets	62.61	73.25	64.89	55.73	40.91	16.62
Total Debt*	25.08	25.86	25.40	25.58	0.38	0.10
Net Current Assets	9.15	39.56	27.39	25.78	21.93	7.76

Cashflow ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	-12.69	-30.89	-18.89	-9.06	-11.78	-5.03
Cash Flow from Investing Activities	--	-1.86	-4.17	-3.75	-6.96	-1.88
Cash from Financing Activities	3.37	38.69	27.76	18.49	27.48	0.13
Net Cash Inflow / Outflow	--	--	4.71	5.69	8.73	-6.76

Financials Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-0.73	-1.41	-1.34	-0.80	-0.56	-0.53
Cash EPS ($)	-0.65	-1.29	-1.20	-0.69	-0.50	-0.42
Adjusted Book Value ($)	0.56	1.43	1.46	1.41	2.38	1.09
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-0.40	-1.29	-0.99	-0.53	-0.84	-0.42
Free Cash Flow per Share ($)	-0.44	-1.36	-1.21	-0.76	-0.95	-0.51

Profitability Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	-45.22	-59.85	-49.66	-32.83	-33.55	-41.99
ROE (%)	-89.47	-109.29	-98.52	-47.68	-33.90	-42.13
ROA (%)	-34.29	-49.08	-42.32	-28.30	-27.35	-34.26
EBIT Margin (%)	-42.21	-65.01	-72.08	-36.58	-22.88	-26.99
Net Margin (%)	-48.18	-91.81	-83.81	-39.68	-23.51	-26.51
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	0.31	0.21	-0.12	0.03	0.39	0.34
EBIT Growth (%)	15.01	-9.36	-74.11	-64.91	-17.93	14.39
Net Profit Growth (%)	31.30	-32.84	-86.63	-73.86	-23.45	52.26
EPS Growth (%)	0.48	-0.05	-0.67	-0.43	-0.06	0.56
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	-0.30	-0.81	-3.54	-5.67	-10.07	-15.44
Price / Book Value	0.40	0.80	3.25	3.23	2.38	7.52
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.95	-1.16	-4.81	-7.14	-10.48	-18.28
Close Price ($)	0.22	1.14	4.75	4.56	5.66	8.20
High Price ($)	1.25	8.75	15.89	7.90	11.55	8.35
Low Price ($)	0.19	1.08	2.25	3.80	4.85	5.05
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	1.41	0.75	0.91	1.06	0.01	0.01
Short term debt to equity ratio	1.10	0.06	0.03	0.03	0.01	0.01
Current Ratio	1.23	3.59	3.22	5.00	4.36	3.51
Quick Ratio	1.04	2.74	2.20	3.51	3.16	2.08
Interest Coverage	-53.41	-8.24	-7.72	-33.75	-12.22	-2,201.21

Operating Efficiency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	38.73	30.98	11.09	10.62	22.07	8.68
Asset Turnover	0.71	0.53	0.50	0.71	1.16	1.29
Receivable days	113.96	73.29	42.21	58.48	51.71	41.59
Inventory Days	97.69	134.67	169.16	142.30	104.62	109.66
Payable days	52.49	71.33	67.86	55.18	43.62	41.44
Cash Conversion Cycle	159.15	136.62	143.51	145.59	112.71	109.81